SCHEMBL22010626

SCHEMBL22010626

COC(=O)c1ccc(CN(C)C)cc1S(=N)(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.44
CA1 P00915 3/20 0.44
CA9 Q16790 3/20 0.44
CA5A P35218 1/20 0.44
CA12 O43570 2/20 0.41
CA7 P43166 2/20 0.41
CA14 Q9ULX7 2/20 0.41
PDK2 Q15119 1/20 0.41
PDK4 Q16654 1/20 0.41
ALDH1A1 P00352 4/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962935 0.89 CA2 (0.54) CA2CA1CA9CA5ACA12
SCHEMBL21962963 0.81 CA2 (0.54) CA2CA1CA9CA5ACA12
SCHEMBL21962901 0.81 KMT2A (0.39) CA2CA1CA9CA5AALDH1A1
SCHEMBL25014612 0.80 LMNA (0.37) CA2CA1CA9CA5AALDH1A1
SCHEMBL21962903 0.79 CA2 (0.38) CA2CA1CA9CA5AALDH1A1
SCHEMBL21962968 0.77 MEN1 (0.36) CA2CA1CA9CA5AALDH1A1
SCHEMBL30925089 0.76 CA2 (0.51) CA2CA1CA9CA5ACA12
SCHEMBL22010261 0.76 CA2 (0.50) CA2CA1CA9CA5ACA12
SCHEMBL3549748 0.76 CA12 (0.57) CA2CA1CA9CA12CA7
SCHEMBL22010625 0.75 CA2 (0.56) CA2CA1CA9CA5ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102100-A9 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2022-01-06 WO disclosed
WO-2020102100-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed